367 related articles for article (PubMed ID: 23932308)
1. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
[TBL] [Abstract][Full Text] [Related]
2. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
[TBL] [Abstract][Full Text] [Related]
3. The effects of CRF and urocortins on the hippocampal glutamate release.
Bagosi Z; Balangó B; Pintér D; Csabafi K; Jászberényi M; Szabó G; Telegdy G
Neurochem Int; 2015 Nov; 90():67-71. PubMed ID: 26216727
[TBL] [Abstract][Full Text] [Related]
4. The effects of the urocortins on the hypothalamic-pituitary-adrenal axis - similarities and discordancies between rats and mice.
Bagosi Z; Csabafi K; Karasz G; Jászberényi M; Földesi I; Siska A; Szabó G; Telegdy G
Peptides; 2019 Feb; 112():1-13. PubMed ID: 30414887
[TBL] [Abstract][Full Text] [Related]
5. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Jászberényi M; Telegdy G
Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347
[TBL] [Abstract][Full Text] [Related]
6. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
7. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
8. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study.
Bagosi Z; Jászberényi M; Szabó G; Telegdy G
Brain Res Bull; 2008 Jan; 75(1):15-7. PubMed ID: 18158090
[TBL] [Abstract][Full Text] [Related]
9. Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.
Chen P; Vaughan J; Donaldson C; Vale W; Li C
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E337-45. PubMed ID: 19952342
[TBL] [Abstract][Full Text] [Related]
10. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
[TBL] [Abstract][Full Text] [Related]
11. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
[TBL] [Abstract][Full Text] [Related]
12. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
Ochedalski T; Subburaju S; Wynn PC; Aguilera G
J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
[TBL] [Abstract][Full Text] [Related]
13. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
Wilson MA; Biscardi R; Smith MD; Wilson SP
J Pharmacol Exp Ther; 1996 Sep; 278(3):1073-82. PubMed ID: 8819488
[TBL] [Abstract][Full Text] [Related]
14. Urocortin 3 modulates the neuroendocrine stress response and is regulated in rat amygdala and hypothalamus by stress and glucocorticoids.
Jamieson PM; Li C; Kukura C; Vaughan J; Vale W
Endocrinology; 2006 Oct; 147(10):4578-88. PubMed ID: 16809443
[TBL] [Abstract][Full Text] [Related]
15. Gestational hypoxia alone or combined with restraint sensitizes the hypothalamic-pituitary-adrenal axis and induces anxiety-like behavior in adult male rat offspring.
Fan JM; Chen XQ; Jin H; Du JZ
Neuroscience; 2009 Apr; 159(4):1363-73. PubMed ID: 19409200
[TBL] [Abstract][Full Text] [Related]
16. Role of urocortin 2 secreted by the pituitary in the stress-induced suppression of luteinizing hormone secretion in rats.
Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E567-75. PubMed ID: 20663987
[TBL] [Abstract][Full Text] [Related]
17. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
[TBL] [Abstract][Full Text] [Related]
18. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
19. Characterization of central and peripheral components of the hypothalamus-pituitary-adrenal axis in the inbred Roman rat strains.
Carrasco J; Márquez C; Nadal R; Tobeña A; Fernández-Teruel A; Armario A
Psychoneuroendocrinology; 2008 May; 33(4):437-45. PubMed ID: 18276081
[TBL] [Abstract][Full Text] [Related]
20. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
